Ignite Creation Date:
2025-12-25 @ 4:11 AM
Ignite Modification Date:
2026-01-29 @ 3:56 PM
Study NCT ID:
NCT02995720
Status:
COMPLETED
Last Update Posted:
2017-08-10
First Post:
2016-12-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin
Sponsor:
Boryung Pharmaceutical Co., Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BR-FARC-CT-103
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None